Authors

Mytheos Holt

Mytheos Holt is Senior Fellow in the Freedom to Innovate at the Institute for Liberty and a 2019 Lincoln Fellow at the Claremont Institute. He has held positions at the R Street Institute, Mair Strategies, TheBlaze, and National Review. He also worked as a speechwriter for U.S. Sen. John Barrasso  His writing on video games has been featured at TheBlaze, Gamesided, the Escapist, and the Federalist. He hails originally from Big Sur, California, but currently lives in Arlington, Virginia. Yes, Mytheos is his real name.
by | Oct 12, 2017

America’s pharmaceutical industry has a problem, and that problem is the rule of law. One can draw no other conclusion, based on the industry’s recent actions. I refer specifically to the pharmaceutical company Allergan’s recent optically baffling attempt to outright…

by | Sep 26, 2017

It is a cliché in Washington that the war on drugs has seen a comeback, thanks almost entirely to the efforts of Attorney General Jeff Sessions. Whether that comeback is as big as advertised is a matter of some debate,…

by | Sep 18, 2017

Here’s a simple question for you: If, every time you faced a particular court, it found against you either unanimously or close to it, would you not do anything possible to avoid that court? To most people, the answer to…

by | Sep 14, 2017

President Donald Trump’s recent decision to investigate China’s theft of American intellectual property (IP) is as good a sign as any that “America First” was more than just a campaign slogan. And when it comes to intellectual property theft, the…

by | Aug 29, 2017

For months, the pharmaceutical industry’s consistent disregard of consumers and bad press has seemed like a setup that was missing a punchline. Critics of the industry have been consistently frustrated as we wait for the other shoe to drop. These…

by | Aug 15, 2017

The crisis of confidence in the pharmaceutical industry remains one of the least well-reported elements of contemporary politics. And despite numerous scandals surrounding mismanagement and price gouging by Pharma companies, the proverbial big Kahuna of the industry’s scandals is undoubtedly…

by | Aug 11, 2017

In 1953, Charles Erwin Wilson, former CEO of General Motors and President Dwight Eisenhower’s nominee for Secretary of Defense, told the U.S. Senate that he had sold his GM stock with a memorable phrase. “For years I thought what was…

by | Jul 25, 2017

When the U.S. Supreme Court handed down the landmark case TC Heartland v. Kraft earlier this year, patent reform advocates breathed a sigh of relief. Here, at last, was the unanimous smackdown that would put an end to venue shopping…

by | Jul 10, 2017

It is a point of cliché that one of the most effective ways to distract a toddler is to shake keys in front of their faces. What has become obvious over the past two weeks is that the same approach…

by | Jul 6, 2017

“Repeal and replace” as a concept was always elegant, particularly as a campaign slogan. In practice, it is consistently proving itself to be harder than its proponents imagined. As with the AHCA before it, it appears that the Senate bill…

Sign up to receive our latest updates! Register


By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact